OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, et al.
Bioimpacts (2022)
Open Access | Times Cited: 19
Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, et al.
Bioimpacts (2022)
Open Access | Times Cited: 19
Showing 19 citing articles:
Small molecule-based immunomodulators for cancer therapy
Yinrong Wu, Zichao Yang, Kui Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4287-4308
Open Access | Times Cited: 67
Yinrong Wu, Zichao Yang, Kui Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4287-4308
Open Access | Times Cited: 67
Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 38
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 38
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
Samik Chakraborty, Juan Ye, Herui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Samik Chakraborty, Juan Ye, Herui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Advancements in Melanoma Therapies: From Surgery to Immunotherapy
Neda Shajari, Behzad Baradaran, Mohammad Reza Tohidkia, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1073-1088
Closed Access | Times Cited: 5
Neda Shajari, Behzad Baradaran, Mohammad Reza Tohidkia, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1073-1088
Closed Access | Times Cited: 5
Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs
Zhuoya Deng, Yuying Tian, Jing Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3607-3621
Open Access
Zhuoya Deng, Yuying Tian, Jing Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3607-3621
Open Access
A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies
Giuseppe Curigliano, M.M. Jimenez, Tomokazu Shimizu, et al.
ESMO Open (2024) Vol. 9, Iss. 8, pp. 103643-103643
Open Access | Times Cited: 2
Giuseppe Curigliano, M.M. Jimenez, Tomokazu Shimizu, et al.
ESMO Open (2024) Vol. 9, Iss. 8, pp. 103643-103643
Open Access | Times Cited: 2
Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination
Tsukasa Seya, Masashi Shingai, Tomomi Kawakita, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1504-1504
Open Access | Times Cited: 6
Tsukasa Seya, Masashi Shingai, Tomomi Kawakita, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1504-1504
Open Access | Times Cited: 6
The role of immune subtyping in glioma mRNA vaccine development
Alexandro Guterres, Mayla Abrahim, Patrícia Neves
Immunotherapy (2023) Vol. 15, Iss. 13, pp. 1057-1072
Closed Access | Times Cited: 6
Alexandro Guterres, Mayla Abrahim, Patrícia Neves
Immunotherapy (2023) Vol. 15, Iss. 13, pp. 1057-1072
Closed Access | Times Cited: 6
Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity
Yehudit Natan, Yigal Dov Blum, Amir Arav, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3785-3785
Open Access | Times Cited: 5
Yehudit Natan, Yigal Dov Blum, Amir Arav, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3785-3785
Open Access | Times Cited: 5
Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeutics
Ritu Ritu, Prakash Chandra, Asmita Das
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4297-4322
Closed Access | Times Cited: 5
Ritu Ritu, Prakash Chandra, Asmita Das
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4297-4322
Closed Access | Times Cited: 5
Ginsenoside Rg3 activates the immune function of CD8+ T cells via circFOXP1-miR-4477a-PD-L1 axis to induce ferroptosis in gallbladder cancer
Zhipeng Ye, Jianfeng Ding, Jie Huang, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 10-11, pp. 793-811
Closed Access | Times Cited: 1
Zhipeng Ye, Jianfeng Ding, Jie Huang, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 10-11, pp. 793-811
Closed Access | Times Cited: 1
Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement
Tsukasa Seya, Megumi Tatematsu, Misako Matsumoto
Cells (2022) Vol. 11, Iss. 24, pp. 4006-4006
Open Access | Times Cited: 7
Tsukasa Seya, Megumi Tatematsu, Misako Matsumoto
Cells (2022) Vol. 11, Iss. 24, pp. 4006-4006
Open Access | Times Cited: 7
INTERVENÇÕES INOVADORAS NA PROMOÇÃO DA SAÚDE: VACINAS TERAPÊUTICAS E ESTRATÉGIAS DE PREVENÇÃO DO HPV
Ingrid Andrêssa de Moura
(2024)
Open Access
Ingrid Andrêssa de Moura
(2024)
Open Access
SHR-1806, a robust OX40 agonist to promote T cell-mediated antitumor immunity
Jun Zhang, Lei Zhou, Xing Sun, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Jun Zhang, Lei Zhou, Xing Sun, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Modulating the tumor microenvironment in a mouse model of colon cancer using a combination of HIF-1α inhibitors and Toll-Like Receptor 7 agonists
Leila Rostamizadeh, Mina Ramezani, Hannaneh Monirinasab, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access
Leila Rostamizadeh, Mina Ramezani, Hannaneh Monirinasab, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access
The possible Role of IFN-γ & TNF-α in bacterial eye infection patients
Israa Ali Abood, Khetam H. Rasool
Reviews in Medical Microbiology (2023) Vol. 34, Iss. 3, pp. 136-139
Closed Access | Times Cited: 1
Israa Ali Abood, Khetam H. Rasool
Reviews in Medical Microbiology (2023) Vol. 34, Iss. 3, pp. 136-139
Closed Access | Times Cited: 1
Synergistic Cytotoxic Effect of Imiquimod and Cisplatin Combination Therapy on A549 Lung Cancer Cell
Leila Rostamizadeh, Behzad Baradaran, Kobra Rostamizadeh, et al.
ImmunoAnalysis (2023) Vol. 3, pp. 5-5
Open Access
Leila Rostamizadeh, Behzad Baradaran, Kobra Rostamizadeh, et al.
ImmunoAnalysis (2023) Vol. 3, pp. 5-5
Open Access
Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review
Ran Ding, Hongguan Jiao, Yuanlin Piao, et al.
Medicine (2023) Vol. 102, Iss. 39, pp. e35506-e35506
Open Access
Ran Ding, Hongguan Jiao, Yuanlin Piao, et al.
Medicine (2023) Vol. 102, Iss. 39, pp. e35506-e35506
Open Access
Vibratome sectioning of tumors to evaluate the interactions between nanoparticles and the tumor microenvironment ex-vivo
Shuhan Liu, Juechao Zhang, Ning-Ning Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access
Shuhan Liu, Juechao Zhang, Ning-Ning Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access
